The Claim
In individuals with chronic fatigue syndrome who test positive for autoantibodies to selenoprotein P, there is no correlation between serum selenium levels and glutathione peroxidase 3 activity, indicating a disruption in selenium delivery to the kidneys despite normal systemic selenium concentrations.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people with chronic fatigue syndrome who have specific autoantibodies, selenium in the blood does not correlate with the activity of an enzyme called glutathione peroxidase 3, suggesting that selenium is not reaching the kidneys properly even though overall selenium levels in the body are normal.
See the scientific wording
In individuals with chronic fatigue syndrome who test positive for autoantibodies to selenoprotein P, the correlation between serum selenium and glutathione peroxidase 3 activity is absent, indicating impaired selenium delivery to the kidneys despite normal systemic selenium levels.
What the research says
1 studyIn some people with chronic fatigue syndrome, their immune system makes antibodies that block selenium from reaching the kidneys, so even if selenium levels in the blood look normal, the kidneys can’t use it properly to make important enzymes.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.